These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21818650)

  • 1. Intrapericardial and retrocardial implantation of implantable cardioverter-defibrillator lead in a child with type 3 long QT syndrome.
    Ichikawa Y; Iwamoto M; Yanagi S; Masuda M
    Pediatr Cardiol; 2011 Oct; 32(7):1048-52. PubMed ID: 21818650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inappropriate pacing inhibition triggered by QT prolongation due to T wave oversensing in an ICD recipient presenting with long QT syndrome.
    Iijima K; Chinushi M; Hasegawa K; Izumi D; Hosaka Y; Furushima H; Aizawa Y
    Intern Med; 2011; 50(9):1021-4. PubMed ID: 21532225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of T-wave oversensing with implantable cardioverter defibrillator generator replacement in an adolescent.
    Tuzcu V
    Pacing Clin Electrophysiol; 2007 Jul; 30(7):929-32. PubMed ID: 17584279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital long QT 3 in the pediatric population.
    Blaufox AD; Tristani-Firouzi M; Seslar S; Sanatani S; Trivedi B; Fischbach P; Paul T; Young ML; Tisma-Dupanovic S; Silva J; Cuneo B; Fournier A; Singh H; Tanel RE; Etheridge SP
    Am J Cardiol; 2012 May; 109(10):1459-65. PubMed ID: 22360817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome by Sex in Patients With Long QT Syndrome With an Implantable Cardioverter Defibrillator.
    Younis A; Aktas MK; Rosero S; Kutyifa V; Polonsky B; McNitt S; Sotoodehnia N; Kudenchuk P; Rea TD; Arking DE; Goldenberg I; Zareba W
    J Am Heart Assoc; 2020 Oct; 9(19):e016398. PubMed ID: 33021160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel minimally invasive, intrapericardial implantable cardioverter defibrillator coil system: a useful approach to arrhythmia therapy in children.
    Hsia TY; Bradley SM; LaPage MJ; Whelan S; Saul JP; Ringewald JM; Reed JH
    Ann Thorac Surg; 2009 Apr; 87(4):1234-8; discussion 1238-9. PubMed ID: 19324158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Jervell and Lange-Nielsen syndrome; atrial pacing combined with ß-blocker therapy, a favorable approach in young high-risk patients with long QT syndrome?
    Früh A; Siem G; Holmström H; Døhlen G; Haugaa KH
    Heart Rhythm; 2016 Nov; 13(11):2186-2192. PubMed ID: 27451284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic lacunae and implications of an automated implantable cardioverter defibrillator implantation in a child with type 3 Long QT (LQT3) syndrome.
    Maddali MM; Kandachar PS; Al-Abri IA; Al-Yamani MI
    Ann Card Anaesth; 2022; 25(2):210-213. PubMed ID: 35417973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter defibrillator therapy in a patient with the idiopathic long QT syndrome.
    Grönefeld G; Höltgen R; Hohnloser SH
    Pacing Clin Electrophysiol; 1996 Aug; 19(8):1260-3. PubMed ID: 8865226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-rate atrial pacing as an innovative bridging therapy in a neonate with congenital long QT syndrome.
    Tanel RE; Triedman JK; Walsh EP; Epstein MR; DeLucca JM; Mayer JE; Fishberger SB; Saul JP
    J Cardiovasc Electrophysiol; 1997 Jul; 8(7):812-7. PubMed ID: 9255689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter defibrillator therapy in children with long QT syndrome.
    Goel AK; Berger S; Pelech A; Dhala A
    Pediatr Cardiol; 2004; 25(4):370-8. PubMed ID: 14994181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillators in patients with long QT syndrome: a multicentre study.
    Zienciuk-Krajka A; Sterliński M; Filipecki A; Owczuk R; Bednarek J; Kempa M; Sielski S; Dziduszko M; Mitkowski P; Kaźmierczak J; Kuśnierz J; Michałkiewicz D; Stec SM; Gułaj M; Majcherek R; Lubiński A; Raczak G
    Kardiol Pol; 2018; 76(12):1687-1696. PubMed ID: 30251242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of electrocardiographic screening failure for the subcutaneous implantable cardioverter-defibrillator in children: A prospective multicenter study.
    Campbell M; Moore JP; Sreeram N; von Alvensleben JC; Shah A; Batra A; Law I; Sanatani S; Thomas V; Nik-Ahd F; Williams S; Nosavan N; Maldonado J; Hart A; Nguyen T; Balaji S
    Heart Rhythm; 2018 May; 15(5):703-707. PubMed ID: 29309839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of an implantable cardioverter-defibrillator in a neonate with LQT3 associated arrhythmias.
    Ten Harkel AD; Witsenburg M; de Jong PL; Jordaens L; Wijman M; Wilde AA
    Europace; 2005 Jan; 7(1):77-84. PubMed ID: 15670972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry.
    Schwartz PJ; Spazzolini C; Priori SG; Crotti L; Vicentini A; Landolina M; Gasparini M; Wilde AA; Knops RE; Denjoy I; Toivonen L; Mönnig G; Al-Fayyadh M; Jordaens L; Borggrefe M; Holmgren C; Brugada P; De Roy L; Hohnloser SH; Brink PA
    Circulation; 2010 Sep; 122(13):1272-82. PubMed ID: 20837891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillator explantation for overdiagnosed or overtreated congenital long QT syndrome.
    Gaba P; Bos JM; Cannon BC; Cha YM; Friedman PA; Asirvatham SJ; Ackerman MJ
    Heart Rhythm; 2016 Apr; 13(4):879-85. PubMed ID: 26681611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subxiphoid approach to epicardial implantation of implantable cardioverter defibrillators in children.
    Haydin S; Saygi M; Ergul Y; Ozyilmaz I; Ozturk E; Akdeniz C; Tuzcu V
    Pacing Clin Electrophysiol; 2013 Aug; 36(8):926-30. PubMed ID: 23668428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden paradoxical QT-interval prolongation exacerbating T-wave alternans in a patient with type 3 long QT syndrome.
    Takasugi N; Goto H; Kuwahara T; Verrier RL
    Ann Noninvasive Electrocardiol; 2015 May; 20(3):290-1. PubMed ID: 25039471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease.
    Breithardt G; Wichter T; Haverkamp W; Borggrefe M; Block M; Hammel D; Scheld HH
    Am Heart J; 1994 Apr; 127(4 Pt 2):1151-8. PubMed ID: 8160595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic prolonged QT interval and QT dispersion: the effects of propofol during implantation of cardioverter-defibrillator.
    Michaloudis D; Fraidakis O; Kanoupakis E; Flossos A; Manios E
    Eur J Anaesthesiol; 1999 Dec; 16(12):842-7. PubMed ID: 10747214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.